After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

More than 90% of RRMS patients given vidofludimus calcium in a clinical trial were free of confirmed disability worsening ...

An unexpected relapse has columnist Ahna Crum contemplating what remains when the miracle of stem cell transplant seems ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...

Soon after initiating gender-affirming hormone therapy, seven of 10 adults with MS showed new signs of disease activity on ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

An experimental medication boosted motor function in mice and primate models of multiple sclerosis by repairing the myelin ...

People who develop MS at a younger age tend to have better long-term physical health but worse mental health than those ...

Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS ...

A study of 125 children with POMS and 145 without major health disorders found that epigenetic age tended to be higher in ...

Columnist Desiree Lama misses the summers when she wasn't dealing with MS and its associated heat intolerance.